Different conbercept injection strategies for the treatment of exudative age-related macular degeneration: A retrospective cohort study

Conbercept is a novel anti-vascular endothelial growth factor for the treatment of age-related macular degeneration (AMD). The most optimal injection strategy is unknown. To assess the effectiveness of intravitreal injection of conbercept using the 3 + pro re nata (PRN) and 3 + Q3 M strategies for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Lei, Tao, Yuan, Liu, Min, Li, Linlin, Zhang, Peng, Wang, Hong, Zhang, Linna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035057/
https://www.ncbi.nlm.nih.gov/pubmed/32049795
http://dx.doi.org/10.1097/MD.0000000000019007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035057/
https://www.ncbi.nlm.nih.gov/pubmed/32049795
http://dx.doi.org/10.1097/MD.0000000000019007

Ejemplares similares